C-MIC: Redefining Heart Failure Therapy

Berlin Heals has developed the C‑MIC Device — a revolutionary, novel, and life‑changing treatment for people with heart failure. This minimally invasive, easy‑to‑implant microcurrent device has shown meaningful clinical benefits, including improved quality of life, greater exercise capacity, better heart‑failure status, and measurable structural improvements in the heart — results never seen before in heart‑failure patients.

The C-MIC Device

A Revolutionary Treatment for Heart Failure

The C‑MIC Device is a breakthrough cardiac implant that activates the heart’s own healing signals to restore function in patients with symptomatic, treatment‑resistant heart failure. This small, minimally invasive device delivers a steady, ultra‑low direct current (DC) that drives reverse remodeling of damaged heart muscle — enabling recovery that was previously out of reach.

Impressive Clinical Results

Patients experienced rapid improvements in heart function, heart size, and quality of life within days to weeks of implantation.

Rapid improvements in heart function, heart size and quality of life of C-MIC placement patients within days of C-MIC placement.
Patients’ average 6-minute walking distance improved by almost 100% after 4 weeks.
Hearts, which were typically enlarged in dilated cardiomyopathies, shrunk in size.
All patients saw their NYHA classification drop by two classes. The NYHA classification is a scheme originally published by the New York Heart Association to classify heart disease according to severity.
The electrical microcurrent remained completely undetectable to the patients and did not interfere with the heart rhythm.
No device-specific side medication or follow-up procedures were required.
Berlin Heals is currently undertaking a European-wide CE Study and is in parallel preparing an Early Feasibility Study in the US.
The patients maintained and increased these improvements for 6 months after implantation.

Heart Failure Explained

Heart Failure is the World’s Most Lethal Disease

Heart failure is a progressive condition that develops when the heart can no longer pump enough blood and oxygen to meet the body’s needs. Despite decades of research, no therapy, drug, or medical technology has ever been able to reverse heart failure — until now.
Berlin Heals was founded in 2014 to change this reality through a truly innovative and groundbreaking approach.

More about Heart Failure

Studies

Study Plan

A First-In-Human study was completed in 2019 with long-term follow-up completed going out to 30months after implant. Then an International Multi-Center Randomized Controlled Trial was completed 2022-2024 and published in 2025. These patients are now being followed for a total duration of 30 months after implant. Then a Less Invasive First-In-Man study was completed in 2025 with results expected in Spring of 2026.

Recent studies

Our recent studies have shown improvement in patient´s quality of life by restoring functional performance of the heart with our microcurrent technology. More about us